Strategic Acquisition The company was acquired by Element Materials Technology in 2021, signaling stronger backing and potential access to broader global testing capabilities, cross-sell opportunities, and expanded service breadth for existing and new customers.

Regulated Excellence With GLP/GMP compliance, FDA registration, DEA licensing, and ISO/IEC 17025:2017 accreditation, the firm demonstrates robust quality frameworks that can reassure prospects in highly regulated sectors such as pharmaceuticals, medical devices, and healthcare.

Healthcare Focus Specialization spans antimicrobial, pharmaceutical, medical device, biotech, and healthcare testing, creating potential to upsell to life sciences companies seeking comprehensive infection prevention and regulatory-ready laboratory support.

Public Health Partnerships Past collaborations with EPA and industry players like Ecolab highlight a track record of public health impact, offering a narrative to engage prospective clients on compliance-driven lab support and environmental testing programs.

Growth Readiness Revenue range and multi-location capabilities under Element ownership indicate scalable capacity and potential for long-term contracts; target prospects include mid-market biotech firms and contract research organizations seeking reliable, compliant lab partners.